Latest Export Growth News

ECS Botanics has reported a return to profitability and positive cash flow in the first half of FY26, driven by a strategic shift to branded products and major infrastructure expansion.

Manuka Resources’ subsidiary Trans-Tasman Resources has received a draft decision proposing to decline consent for its Taranaki VTM iron sands project, challenging the company’s plans to develop a critical minerals supply in New Zealand.

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

BPH Global Ltd has recorded its second highest monthly seaweed sales since May 2025, driven by a strategic shift towards independent operations in Indonesia. The company’s aggregate sales now exceed A$2.15 million, underpinning its growth ambitions for 2026.

ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.

Dalrymple Bay Infrastructure Limited has reaffirmed its position as the world’s largest metallurgical coal export facility with full contracted capacity through 2028 and unveiled detailed plans for a significant terminal expansion.

Netlinkz Limited reports steady customer receipts and strategic investments in its Securelink joint venture, while preparing for an ASX relisting and a rebrand to Securelink Networks Ltd.

Lark Distilling Co. reported a 10% increase in net sales for Q1 FY26, driven by strong domestic and Asian export growth, while preparing for a major brand restage and leadership change.

AnteoTech Ltd reports strong quarterly progress with a key US joint development agreement, significant manufacturing scale-up, and expanded market access in South Korea, underpinning its 2025 commercialisation strategy.

ARB Corporation Limited reported a 5.3% increase in FY25 sales revenue to A$729.9 million, driven by strong export growth and strategic US market moves, despite a 5% dip in profit after tax.

Cann Group Limited has reported its first-ever EBITDA-positive month in August 2025, driven by strong B2B flower sales and disciplined cost management. The company is advancing export negotiations in Europe and preparing to launch a new Botanitech product range.

Mayne Pharma reported a robust 5% revenue increase to $408.1 million and more than doubled its underlying EBITDA to $47 million in FY25, driven by strong Women’s Health sales and strategic acquisitions in Dermatology.